Back to Market Feed

This NDC is on FDA's drug shortage list (posted Oct 12, 2022)

Product Information

DEXTROAMP-AMPHETAM 12.5 MG TAB is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.3592 per EA under NDC 11534019301. Its NADAC has been published 317 times since Sep 9, 2020.

FDA first approved this application on Dec 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

3.125; 3.125; 3.125; 3.125 mg/1; mg/1; mg/1; mg/1

NDC

11534019301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209799

FDA Approved

12/28/2017

TE Code

AB

On Market Since

7/4/2018

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has been published 317 times since Sep 9, 2020, and over the history we have for it it has declined 50.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3592 per EA
All-time high$0.8057 (Jun 16, 2021)
All-time low$0.2862 (Nov 20, 2024)
52-week high$0.3621
52-week low$0.3065
Median price$0.5146
Average price$0.5007
Largest weekly change+70.2% (Dec 21, 2022)
Weeks tracked317
Tracking sinceSep 9, 2020

Price History

1W

0.0%

1M

+4.3%

3M

+8.8%

6M

+13.7%

1Y

-0.8%

3Y

-32.5%

5Y

-33.8%

All

-50.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

BACK-BODY PAIN 500-32.5 MG CPLT
Generic
70000012702•Cardinal Health
$0.0422
per EA
EXTRA PAIN RELIEF CAPLET
Generic
49483037000•Time-Cap Labs Inc.
$0.0621
per EA
TENSION HEADACHE CAPLET
Generic
70000015901•Cardinal Health
$0.0622
per EA
TENSION HEADACHE CAPLET
Generic
70000015902•Cardinal Health
$0.0622
per EA
QC HEADACHE RELIEF TABLET
Generic
63868048501•Chain Drug Marketing Association
$0.0629
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037462•L. Perrigo Company
$0.0648
per EA
GS MIGRAINE 250-250-65 MG CPLT
Generic
00113037478•L. Perrigo Company
$0.0648
per EA
PAIN RELIEVER PLS 250-250-65 MG
Generic
00536132601•Rugby Laboratories
$0.0648
per EA
MIGRAINE 250-250-65 MG CPLT
Generic
24385036571•AmerisourceBergen
$0.0648
per EA
MIGRAINE FORMULA CAPLET
Generic
24385036578•AmerisourceBergen
$0.0648
per EA

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Manufacturer

Sunrise Pharmaceutical Inc. manufacturer profile

See the full portfolio, pricing trend, and other products from this labeler.

Drug market

dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate market comparison

Compare this molecule across participating manufacturers and inspect the broader market price spread.

Therapeutic class

Central Nervous System Stimulant class view

See how this drug behaves alongside other products in the same FDA pharmacologic class.

Trend hub

Latest market trends

Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.

Guide

Understanding NADAC pricing

Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAM 12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAM 12.5 MG TAB, manufactured by Sunrise Pharmaceutical Inc., is $0.3592 per EA (NDC 11534019301), effective Sep 30, 2026.

How has the price of DEXTROAMP-AMPHETAM 12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has declined 50.9%. It has been tracked across 317 weekly CMS publications since Sep 9, 2020.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAM 12.5 MG TAB?

Since Sep 9, 2020, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has ranged from a low of $0.2862 (Nov 20, 2024) to a high of $0.8057 (Jun 16, 2021), with a median of $0.5146 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAM 12.5 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAM 12.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DEXTROAMP-AMPHETAM 12.5 MG TAB?

DEXTROAMP-AMPHETAM 12.5 MG TAB (NDC 11534019301) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.

Is DEXTROAMP-AMPHETAM 12.5 MG TAB in shortage?

Yes — NDC 11534019301 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).